16 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Mar 2027. from the record

Free plan: 3 watched companies. Pro: unlimited.

Alerts on its grants, lapses and transfers.

Ending by 2030

Mar 2027

Next term end

Patent families

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027 202820292030203120322033203420352036203720382039 2040 20412042204320442045

notable patents all others Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Notable

Nanoemulsion Formulation with Improved Stability and Cell Penetration US 11,540,981

The most cited patent in this portfolio, cited by 39 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2028.

Ends Feb 2028 · High confidence Also notable

LED Panel for a Photodynamic Therapy Lamp US D1,021,120

Cited by 7 later US patents, top 25% of design patents granted in 2024 in our data. Protection runs to 2039.

Ends Apr 2039 · High confidence Also notable

Illumination for Photodynamic Therapy US 11,219,781

The earliest of the three still in force, granted 2022 and renewed since. Its term ends first, in 2039.

Ends Jun 2039 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 10, 2027.

Recent changes

Oct 20Assignment recorded on 5 records: Biofrontera Pharma GmbH to Biofrontera, Inc. Recorded Oct 20, 2026, executed Sep 22, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76724, frame 292.
2 of the patents on this record were granted since Aug 16, 2026

What they patent

The 5 largest of its 10 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Illumination Device for Photodynamic Therapy, Method for Treating a Skin Disease and Method for Operating an Illumination Device	4 in force	to Sep 2041
Illumination for Photodynamic Therapy	2 in force	to Sep 2041
Photodynamic Therapy Lamp Head	2 in force	to Aug 2041
Photodynamic Therapy Comprising Two Light Exposures at Different Wavelengths	2 in force	to Apr 2039
Nanoemulsion Formulation with Improved Stability and Cell Penetration	1 in force	to Feb 2028

Patents held now

Soonest term end first.

Patent	Title	Status	Expires	Confidence
US 7,517,101	Convertible Lamp Array In force Term ends Mar 27, 2027 · High confidence	In force	Term ends Mar 27, 2027	High confidence
US 11,540,981	Nanoemulsion Formulation with Improved Stability and Cell Penetration In force Term ends Feb 7, 2028 · High confidence	In force	Term ends Feb 7, 2028	High confidence
US 12,544,443	Photodynamic Therapy Comprising Two Light Exposures at Different Wavelengths In force Term ends Mar 8, 2039 · High confidence	In force	Term ends Mar 8, 2039	High confidence
US D1,021,120	LED Panel for a Photodynamic Therapy Lamp In force Term ends Apr 2, 2039 · High confidence	In force	Term ends Apr 2, 2039	High confidence
US 11,642,411	Photodynamic Therapy Comprising Two Light Exposures at Different Wavelengths In force Term ends Apr 23, 2039 · High confidence	In force	Term ends Apr 23, 2039	High confidence
US 11,219,781	Illumination for Photodynamic Therapy In force Term ends Jun 5, 2039 · High confidence	In force	Term ends Jun 5, 2039	High confidence
US D1,052,103	Photodynamic Therapy Lamp Head In force Ends no later than Nov 19, 2039 · Medium confidence	In force	Ends no later than Nov 19, 2039	Medium confidence
US D1,067,446	Photodynamic Therapy Lamp In force Term ends Nov 19, 2039 · Medium confidence	In force	Term ends Nov 19, 2039	Medium confidence
US 11,235,169	Illumination Device for Photodynamic Therapy, Method for Treating a Skin Disease and Method for Operating an Illumination Device In force Term ends Oct 15, 2040 · High confidence	In force	Term ends Oct 15, 2040	High confidence
US 12,472,374	Illumination Device for Photodynamic Therapy, Method for Treating a Skin Disease and Method for Operating an Illumination Device In force Term ends Oct 15, 2040 · High confidence	In force	Term ends Oct 15, 2040	High confidence

10 of 16 patents shown.

Pro members see all 16.

Pro members: see all 16 patents

Also on record, not counted in the 16: 8 applications pending. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built

Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

1 terminal disclaimer is on file with no resolved reference. No cap is applied and none is guessed

Export every term end as CSV · Pro

Biofrontera, Inc.